Antenatal Diagnosis of HIV and SyphilisGeeta Shakyam*
National Public Health Laboratory, Teku, Kathmandu, Nepal
- *Corresponding Author:
- Geeta Shakya
Former Director of National Public Health Laboratory
Teku, Kathmandu, Nepal
Tel: 977-1-4240217; 9841240312
E-mail: [email protected]
Received date: May 04, 2017; Accepted date: June 01, 2017; Published date: June 07, 2017
Citation: Shakya G (2017) Antenatal Diagnosis of HIV and Syphilis. J AIDS Clin Res 8:701. doi:10.4172/2155-6113.1000701
Copyright: © 2017 Shakya G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The diagnosis of 90% of people with HIV is the first target of United Nations UNAIDS 90:90:90 visions for 2020, to end the AIDS epidemic by 2030. Antenatal HIV testing is an important step forward in achieving this and the elimination of mother-to-child transmission (EMTCT) of HIV, which is validated by world health organization. This is possible through universal antenatal screening for HIV and effective intervention. A screening tool, useable as a point-of-care (POC) test is essential for HIV testing in the antenatal clinics. We evaluated the performance of SD Bioline HIV/syphilis Duo rapid test kits in this regard, in Nepal and found it a good screening tool with added opportunity for simultaneous diagnosis of HIV and syphilis. Currently, as it is commercially available at affordable cost, screening of pregnant women for syphilis and HIV has become feasible with the potential to form an integral part of improving maternal and child health.